RxDoctor Payments Data

Robison Chan, MD

Ophthalmology · Chicago, ILNPI 1144204397

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $66,990 of the $81,129 with a category attached, or 82.6%. Alcon accounts for 88.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $28,516 and has fallen 50.7% since, to $14,045 in 2025. Among ophthalmology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,129in general payments, 2019–2025

Across 57 payments — averaging $1423.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$72K
  • AbbVie$3K
  • Genentech USA, Inc.$3K
  • Eyepoint US, Inc.$2K
  • Carl Zeiss Meditec USA, Inc.$390
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$144
  • plus $102 from 2 others
$56,087in research payments, 2019–2025

Across 13 payments — averaging $4314.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$31K
  • Janssen Research & Development, LLC$25K

What the payments were for

  • Consulting fees$66,99083%
  • Speaking & faculty fees$7,7009%
  • Travel & lodging$3,9395%
  • Food & beverage$2,5003%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,129 in reported general payments places this provider in the 95th percentile of 773 ophthalmology providers in Illinois.

See all ophthalmology providers in Illinois

Medicare billing

Part B allowed, 2024
$24,005
Medicare patients
80
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →